EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery

Nazma F Ilahibaks, Arif I Ardisasmita, Songpu Xie, Anders Gunnarsson, Joseph Brealey, Pieter Vader, Olivier G de Jong, Saskia de Jager, Niek Dekker, Ben Peacock, Raymond M Schiffelers, Joost P G Sluijter und 1 weitere

Journal of Controlled Release · 2023-03 · 355 · 579-592

DOI: 10.1016/j.jconrel.2023.02.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-03. Verfasst von Nazma F Ilahibaks und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Cardiology, Department Heart & Lungs, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands. Hauptthemen laut MEDLINE: Extracellular Vesicles. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) have emerged as biocompatible drug delivery vehicles due to their native ability to deliver bioactive cargo to recipient cells. However, the application of EVs as a therapeutic delivery vehicle is hampered by effective methods for endogenously loading target proteins inside EVs and unloading proteins after delivery to recipient cells. Most EV-based engineered loading methods have a limited delivery efficiency owing to their inefficient endosomal escape or cargo release from the intraluminal attachment from the EV membrane. Here, we describe the 'Technology Of Protein delivery through Extracellular Vesicles' (TOP-EVs) as a tool for efficient intracellular delivery of target proteins mediated via EVs. The vesicular stomatitis virus glycoprotein and the rapamycin-heterodimerization of the FKBP12/T82L mutant FRB proteins were both important for the effective protein delivery through TOP-EVs. We showed that TOP-EVs could efficiently deliver Cre recombinase and CRISPR/Cas9 ribonucleoprotein complex in vitro. Moreover, our results demonstrated that the capacity of TOP-EVs to deliver intracellular proteins in recipient cells was not an artifact of plasmid contamination or direct plasmid loading into EVs. Finally, we showed that TOP-EVs could successfully mediate intracellular protein delivery in the liver in vivo. Taken together, TOP-EVs are a versatile platform for efficient intracellular protein delivery in vitro and in vivo, which can be applied to advance the development of protein-based therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesCell CommunicationDrug Delivery SystemsEndosomesTechnology

Stichwörter der Autor:innen

Active protein loadingExtracellular vesiclesFunctional intracellular protein deliveryGenome editingTOP-EV

Autor:innen und Institutionen

  • Laboratory of Experimental Cardiology, Department Heart & Lungs, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands.
  • Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Mölndal 43183, Sweden.
  • NanoFCM Co., Ltd, MediCity, D6 Thane Road, Nottingham NG906BH, United Kingdom.
  • Laboratory of Experimental Cardiology, Department Heart & Lungs, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands; CDL Research, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands.
  • Department of Pharmaceutics, Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht 3584 CG, the Netherlands.
  • CDL Research, University Medical Center Utrecht, Utrecht 3584 CX, the Netherlands.

Zitieren

APA

Ilahibaks, N. F., Ardisasmita, A. I., Xie, S., Gunnarsson, A., Brealey, J., Vader, P., de Jong, O. G., de Jager, S., Dekker, N., Peacock, B., Schiffelers, R. M., Sluijter, J. P. G., & Lei, Z. (2023). TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery. Journal of Controlled Release, 355, 579-592. https://doi.org/10.1016/j.jconrel.2023.02.003

Vancouver

Ilahibaks NF, Ardisasmita AI, Xie S, Gunnarsson A, Brealey J, Vader P, et al. TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery. Journal of Controlled Release. 2023;355:579-592. doi:10.1016/j.jconrel.2023.02.003

BibTeX
@article{Ilahibaks2023,
  author = {Ilahibaks, Nazma F and Ardisasmita, Arif I and Xie, Songpu and Gunnarsson, Anders and Brealey, Joseph and Vader, Pieter and de Jong, Olivier G and de Jager, Saskia and Dekker, Niek and Peacock, Ben and Schiffelers, Raymond M and Sluijter, Joost P G and Lei, Zhiyong},
  title = {TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery},
  journal = {Journal of Controlled Release},
  year = {2023},
  volume = {355},
  pages = {579--592},
  doi = {10.1016/j.jconrel.2023.02.003}
}
Kostenlos starten →